Abiracure 250 mg Tablet is a medication used together with steroid medicine prednisone or methylprednisolone to treat prostate cancer. Abiracure Tablet is usually used in adult men whose prostate cancer has spread to other parts of the body and who have not responded to other forms of treatment, such as chemotherapy. Abiracure 250 stops your body from making testosterone, which can slow the growth of prostate cancer. It is important to note that Abiracure 250 Tablet is not a cure for prostate cancer, it can be managed and the progression of the disease can be slowed.
Abiracure is not safe for use in women. It is not known if Abiracure Tablet is safe and effective in females or children
Abiracure Tablet is usually taken by mouth once a day on an empty stomach. Do not eat food 2 hours before and 1 hour after taking Abiracure 250 Tablet. Abiracure 250 common side effects of the medication may include fatigue, joint pain, hot flashes, and nausea. More serious side effects, such as liver damage and low blood pressure, may also occur. It is important to discuss the potential risks and benefits of treatment with your doctor before starting Abiracure.
It's important before taking Abiracure 250 Tablet to inform your doctor if you have any pre-existing disease like liver disease, lung disease, diabetes, adrenal or pituitary gland problems or if you are using any medications or vitamins, Herbal medicines, etc. Additionally, inform them if you are pregnant, planning to become pregnant, or breastfeeding. The use of effective birth control (contraception) by both males and females during treatment with Abiracure 250 Tablet for 3 weeks to avoid pregnancy. Regular monitoring of your blood glucose levels while on treatment.
Prostate cancer: Abiracure 250 mg Tablet is used to treat prostate cancer, a type of cancer that occurs in the prostate, a gland of the male reproductive system. It is one of the most common cancers in men. Symptoms of prostate cancer include difficulty urinating, frequent urination, and pain or burning during urination.
Abiracure 250 Tablet decreases the production of testosterone in males. In this way, the cancer cells decrease or stop growing due to low testosterone levels in the body.
Abiracure Tablet can slow the growth of prostate cancer cells and reduce the size of tumours.
Abiracure Tablet can delay the need for other treatments such as chemotherapy or radiation therapy and prolong survival in people with advanced prostate cancer.
Abiracure is an androgen synthesis inhibitor. Abiracure 250 works by blocking the action of an enzyme called CYP17A1, which is involved in the production of testosterone in the body. By inhibiting the production of testosterone, a hormone that can stimulate the growth of prostate cancer cells.
Abiracure 250 mg Tablet is unlikely to affect your ability to drive or operate machinery. If you experience any side effects while taking Abiracure Tablet such as dizziness or drowsiness, it is important to avoid driving or operating heavy machinery until the side effects have resolved.
It is not recommended to breastfeed while taking Abiracure. Abiracure Tablet may pass into breast milk and harm the infant. If you are breastfeeding and taking Abiracure 250, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
Abiracure 250 Tablet is safe to use in patients with kidney disease. No dose adjustment of Abiracure Tablet is recommended. If you experience any side effects please consult your doctor.
It is important to use caution when taking Abiracure Tablet if you have liver disease, as the dose of the medication may need to be adjusted. It is recommended to consult with your doctor about the appropriate use of this medication in your specific situation.
It is generally not recommended to drink alcohol while taking Abiracure. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
Use of Abiracure Tablet may be unsafe during pregnancy as animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Abiracure 250 during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
1. Zytiga, Abiraterone Acetate, Janssen-cilag (new Zealand) Ltd, [Date Of Revison 17 Nov 2022, Product Leaflet
2. Abiraterone Acetate, Food And Drug Administration Center For Drug Evaluation And Research , India, Available Form
3. Abiraterone Acetate Tablets, For Oral Use, Msn Laboratories Private Limited, India, Product Leaflet
4. Zytiga, (abiraterone Acetate) , Janssen Biotech, Inc.[last Updated September 2021], Available Form
5. Zytiga, (abiraterone Acetate) Tablets, Patheon Inc., Mississauga, Canada, Product Monograph
6. Zytiga 250 Mg Tablets, Janssen-cilag Spa, Product Leaflet